New dialysis anemia drug tested for safety in 2,200 patients
Disease control
Ongoing
This study looks at the safety of a drug called vadadustat for treating anemia in people with kidney failure who are on dialysis. About 2,200 adults will be randomly assigned to take vadadustat three times a week or continue standard care. The goal is to see if this dosing schedu…
Phase: PHASE3 • Sponsor: USRC Kidney Research • Aim: Disease control
Last updated May 17, 2026 13:59 UTC